There are 54 papers on metabolic score for insulin resistance in aging research: 1 trial and 52 observational studies in people, 1 review.
54 papers study it80 more mention it35 findings
16 new papers in 30 daysSee all 134 papers on metabolic score for insulin resistance
“METS-IR exhibited the strongest association with overall LC, with the highest quartile associated with an increased risk”
- Human trial1
- Humans52
Effects
1Kidney stone disease risk reclassification
upin humans1
1 study
Kidney stone disease risk reclassification
upin humans1
Metabolic score for insulin resistance is linked with better kidney stone disease risk reclassification in humans (Compared with body mass index alone) (NRI 0.107, 95% CI 0.011–0.196).
“METS-IR provided a significant incremental risk reclassification benefit over body mass index (BMI) alone (NRI =0.107, 95% CI: 0.011-0.196).”
HumansCompared with body mass index alone54.2% malesn = 39,305
Translational andrology and urology
Upstream
1Physical capability
downin humans1
1 study
Physical capability
downin humans1
Physical capability is linked with lower metabolic score for insulin resistance in humans (both P ≤ 0.03).
“increases in walking speed or grip strength were related to reduced metabolic score for insulin resistance (both P ≤ 0.03).”
Humans4 yearsn = 1,667
Diabetes research and clinical practice
Associations
25Cardiovascular mortality
upin humans2mixedin humans1HR 1.29–1.91
3 studies
Cardiovascular mortality
upin humans2mixedin humans1HR 1.29–1.91
Metabolic score for insulin resistance predicts cardiovascular mortality in humans (Peritoneal dialysis patients with end-stage renal disease; exploratory METS-IR cutoff 33.3) (AUC 0.617 (95% CI 0.557–0.677); sensitivity 75.3%, specificity 48.3% at cutoff 33.3).
“with an AUC (95% CI) of 0.617 (0.557–0.677; p < 0.001), indicating modest discrimination.”
HumansPeritoneal dialysis patients with end-stage renal disease; exploratory METS-IR cutoff 33.3n = 553
PloS one
Metabolic score for insulin resistance is associated with cardiovascular mortality in humans (Highest versus lowest tertile: HR 1.91 (95% CI 1.03–3.55); second versus lowest tertile: HR 1.90 (95% CI 1.01–3.61)).
“those in tertile 3 was associated with an HR of 1.91 (95% CI, 1.03–3.55) compared with tertile 1.”
HumansPeritoneal dialysis patients with end-stage renal disease; highest versus lowest METS-IR tertile, fully adjusted modeln = 553
PloS one
Metabolic score for insulin resistance is associated with cardiovascular mortality in humans (Cardiovascular patients with cardiometabolic conditions; METS-IR above 48.9) (HR 1.29, 95% CI 1.04–1.61 above threshold 48.9).
“Above their respective inflexion points, both markers demonstrated a positive correlation with CV mortality”
HumansCardiovascular patients with cardiometabolic conditions; METS-IR above 48.9Average follow-up, 7.6±6.7 years78.8% malesn = 1,720
ESC Congress 2026 abstract
Metabolic score for insulin resistance is associated with cardiovascular mortality in humans (cardiovascular–kidney–metabolic syndrome stage 2) (U-shaped association; risk rose sharply above METS-IR ≈ 46.8).
“TyG and METS-IR exhibited U-shaped curves: risk rose sharply above TyG = 8.78 and METS-IR ≈ 46.8.”
Humanscardiovascular–kidney–metabolic syndrome stage 2Median follow-up of 103 monthsn = 13,098
Diabetology & metabolic syndrome
Cardiometabolic multimorbidity
upin humans2OR 7.89
2 studies
Cardiometabolic multimorbidity
upin humans2OR 7.89
Metabolic score for insulin resistance predicts cardiometabolic multimorbidity in humans (CHARLS cohort) (AUC = 0.712).
“METS-IR had moderate predictive value (AUC = 0.712 in CHARLS, 0.618 in clinical data), outperforming CCR.”
HumansCHARLS cohort
Frontiers in endocrinology
Metabolic score for insulin resistance is linked with a higher risk of cardiometabolic multimorbidity in community and clinical cohorts.
“METS-IR was independently and dose-dependently associated with increased CMM risk.”
Humansin community and clinical cohorts
Frontiers in endocrinology
Metabolic score for insulin resistance is associated with cardiometabolic multimorbidity in humans (Hypertensive patients; adjusted for confounding factors) (OR 7.89 (95% CI 6.76–9.22)).
“higher METS-VF, METS-IR, and CMI were all risk factors for CMM”
HumansHypertensive patients; adjusted for confounding factorsn = 16,303
Scientific reports
Lung cancer
upin humans1downin humans1HR 0.8–1.24
2 studies
Lung cancer
upin humans1downin humans1HR 0.8–1.24
Metabolic score for insulin resistance is associated with lung cancer in humans (Highest METS-IR quartile; fully adjusted Cox regression) (HR 1.24, 95% CI 1.05–1.47).
“METS-IR exhibited the strongest association with overall LC, with the highest quartile associated with an increased risk”
HumansHighest METS-IR quartile; fully adjusted Cox regressionMedian follow-up of 13.25 yearsn = 388,013
BMC cancer
Metabolic score for insulin resistance is linked with a lower risk of lung cancer in humans (fully adjusted Cox regression model) (HR 0.80, 95% CI 0.74-0.86; p for trend < 0.001).
“In fully adjusted Cox regression models, using Q1 as the reference group, higher METS-IR quartiles were associated with a significantly lower risk of lung cancer”
Humansfully adjusted Cox regression modelQ4 vs Q19.5 years median follow-upn = 322,624
Cancers
Mild cognitive impairment
mixedin humans1downin humans1HR 0.65
1 study
Mild cognitive impairment
mixedin humans1downin humans1HR 0.65
Metabolic score for insulin resistance is associated with mild cognitive impairment in humans (overall sample, nonlinear analysis).
“Restricted cubic spline analyses showed a significant nonlinear association between METS-IR and incident MCI in the overall sample (P for overall < .001, P for nonlinear = .017).”
Humansoverall sample, nonlinear analysisn = 4,980
Medicine
Metabolic score for insulin resistance is linked with a lower risk of mild cognitive impairment in humans (quartile 3 vs quartile 1) (HR 0.65, 95% CI 0.53-0.78).
“hazard ratios for incident MCI were 0.94 (95% confidence interval [CI]: 0.79-1.11) for quartile 2, 0.65 (95% CI: 0.53-0.78) for quartile 3, and 0.72 (95% CI: 0.59-0.87) for quartile 4.”
Humansquartile 3 vs quartile 1n = 4,980
Medicine
Dyslipidemia
upin humans1
1 study
Dyslipidemia
upin humans1
Metabolic score for insulin resistance is linked with a higher risk of dyslipidemia in humans (longitudinal analysis) (P for trend < 0.05).
“In longitudinal analysis, TyG, TyG-BMI, TyG-WC, TyG-WHtR, METS-IR, and TG/HDL-C were positively associated with the risk of new-onset dyslipidaemia (P for trend < 0.05).”
Humanslongitudinal analysismedian 1,874 daysn = 1,033
BMC endocrine disorders
Metabolic score for insulin resistance predicts dyslipidemia in humans (longitudinal analysis) (importance score 0.105).
“feature importance assessment and Shapley additive interpretation (SHAP) analysis further confirmed METS-IR as the best predictor of dyslipidemia with an importance score of 0.105.”
Humanslongitudinal analysismedian 1,874 daysn = 1,033
BMC endocrine disorders
White matter hyperintensity burden
upin humans1
1 study
White matter hyperintensity burden
upin humans1
Metabolic score for insulin resistance is associated with white matter hyperintensity burden in humans after adjustment for demographic, socioeconomic, lifestyle and vascular risk factors.
“Higher METS-IR was associated with greater WMH burden after adjustment for demographic, socioeconomic, lifestyle and vascular risk factors.”
Humansafter adjustment for demographic, socioeconomic, lifestyle and vascular risk factorsbrainn = 59,826
The International journal of neuroscience
Metabolic dysfunction-associated steatotic liver disease
upin humans1OR 3.65
1 study
Metabolic dysfunction-associated steatotic liver disease
upin humans1OR 3.65
Metabolic score for insulin resistance is associated with metabolic dysfunction-associated steatotic liver disease in humans (Adjusted OR 3.65 in Chinese participants and 2.90 in Japanese participants; all P < 0.001).
“Fully adjusted odds ratios per standard deviation increase in TyG, TyG-BMI, METS-IR and SPISE were 2.39, 5.09, 3.65 and 0.15 in the Chinese cohort”
HumansNonobese Chinese longitudinal and Japanese cross-sectional cohorts; per standard deviation increase
Scientific reports
More on Metabolic dysfunction-associated steatotic liver disease
Progression to stage 4 cardiovascular-kidney-metabolic syndrome
upin humans1HR 1.11
1 study
Progression to stage 4 cardiovascular-kidney-metabolic syndrome
upin humans1HR 1.11
Metabolic score for insulin resistance is associated with progression to stage 4 cardiovascular-kidney-metabolic syndrome in humans (Baseline cardiovascular–kidney–metabolic syndrome stages 0–3; fully adjusted model) (HR 1.11 per 1-SD increase (95% CI 1.07–1.14); fourth versus first quartile HR 2.03 (95% CI 1.64–2.52); p for trend <0.001).
“each 1-standard-deviation increase in METS-IR was associated with a hazard ratio of 1.11 (95% confidence interval, 1.07–1.14)”
HumansBaseline cardiovascular–kidney–metabolic syndrome stages 0–3; fully adjusted modelEach 1-standard-deviation increaseMedian 7-year follow-upn = 31,286
Medicina (Kaunas, Lithuania)
More on Progression to stage 4 cardiovascular-kidney-metabolic syndrome
sRAGE
mixedin humans1
1 study
sRAGE
mixedin humans1
Metabolic score for insulin resistance is associated with sRAGE in humans (Biomarker subset; accounting for HOMA-IR).
“Of these, HOMA-IR, sex, age, SBP, lipid-lowering medication, sRAGE and leptin remained significantly correlated to METS-IR.”
HumansBiomarker subset; accounting for HOMA-IRplasma33% mens
ESC Congress 2026 abstract
Leptin
mixedin humans1
1 study
Leptin
mixedin humans1
Metabolic score for insulin resistance is associated with leptin in humans (Biomarker subset; accounting for HOMA-IR).
“Of these, HOMA-IR, sex, age, SBP, lipid-lowering medication, sRAGE and leptin remained significantly correlated to METS-IR.”
HumansBiomarker subset; accounting for HOMA-IRplasma33% mens
ESC Congress 2026 abstract
All 25Fewer
Latest
90 papers in 12 monthsFrequency-Specific Associations of the Triglyceride-Glucose Index and Previously Unrecognized Diabetes-Range Glycemia With Hearing Thresholds in Chinese Adults Aged 20-59 Years: A Cross-Sectional Study
Association of metabolic insulin resistance with white matter hyperintensity burden and plasma proteomic signatures in the UK Biobank
Association between metabolic score for insulin resistance trajectories and the risk of kidney stone disease: a retrospective cohort study
Comparison of four insulin resistance surrogate indices for incident MASLD in Chinese and prevalent MASLD in Japanese nonobese adults
Associations of insulin resistance surrogates with cardiovascular disease in early stage cardiovascular–kidney–metabolic syndrome: a prospective cohort study
Nonlinear association of TyG index and METS-IR with cardiovascular mortality in cardiometabolic patients: a long-term cohort study
External validation reveals setting-dependent performance of TyG-related indices for HbA1c-defined prediabetes
See all 134 papers on metabolic score for insulin resistance